Author:
Orsola A.,Palou J.,Xavier B.,Algaba F.,Salvador J.,Vicente J.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunotherapy;Bladder Cancer;2018
2. Prediction models for progression of non-muscle-invasive bladder cancer: A review;International Journal of Urology;2017-12-16
3. The predictive value of GSTT1 polymorphisms in predicting the early response to induction BCG therapy in patients with non–muscle invasive bladder cancer11Basic Science Research Program, the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology (2011–0023308) and by a Grant from the Next-Generation BioGreen 21 Program (No. PJ008195), Rural Development Administration, Republic of Korea. The biospecimens for this study were provided by the Chungbuk National University Hospital, a member of the National Biobank of Korea, which is supported by the Ministry of Health, Welfare and Family Affairs. All samples derived from the National Biobank of Korea were obtained with informed consent under institutional review board–approved protocols.;Urologic Oncology: Seminars and Original Investigations;2014-05
4. Impact of bladder neck involvement on progression in patients with primary non–muscle invasive bladder cancer: A prospective validation study;Urologic Oncology: Seminars and Original Investigations;2014-01
5. Non–Muscle-Invasive Bladder Cancer (Ta, T1, and CIS);Campbell-Walsh Urology;2012